• Trinity Biotech amended Warrant Certificate No. 2 to set the exercise price at $5.90 per ADS, subject to adjustment.
• A resale registration amendment must be filed within 30 days of determining it is required to reflect the revised exercise price.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554855-26-002349), on November 12, 2026, and is solely responsible for the information contained therein.